Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Elutia Inc ELUT

Healthcare Medical Devices
Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women’s Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides... see more

Current News (NDAQ:ELUT)

Elutia to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19

GlobeNewswire March 17, 2026

Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire March 13, 2026

Elutia Reports Fourth Quarter and Full Year 2025 Financial Results; Initiates NXT-41 Regulatory Process

GlobeNewswire March 11, 2026

Elutia Regains Compliance with Nasdaq Listing Requirements

GlobeNewswire March 4, 2026

Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market

GlobeNewswire March 2, 2026

Elutia to Report Fourth Quarter 2025 Financial Results on Wednesday, March 11, 2026

GlobeNewswire February 25, 2026

Where Purpose Meets Performance: Elutia Earns 2026 Great Place to Work Certification(TM)

GlobeNewswire February 18, 2026

Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x Milestones

GlobeNewswire January 12, 2026

Elutia to Present at Global BioInnovation Forum on NXT-41x Biomatrix Program for Plastic and Reconstructive Surgery

GlobeNewswire January 9, 2026
View More News ››

Opinion & Analysis (NDAQ:ELUT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ELUT)

Elutia Inc. (NASDAQ:ELUT) – Pioneering Drug-Eluting Bi

http://beyondspx.com/2024/08/01/elutia-inc-nasdaqelut-pioneering-drug-eluting-biomatrices-to-disrupt-the-medical-device-market/
MikeTester - August 1, 2024

ELUT ....low volume but..........

There is some buying pressure and price appeciation Small position On watch for a huge upswing.....JMHO ; )
Iseneschal - September 28, 2023

RE:ELUT....not bad so far....nice lil pop to H.O.D

Wortha repeat ? Hell ya
Iseneschal - September 26, 2023

ELUT ....Anyone BTFD ....L.O.D at $1.16

Ya pays yo money and yo takes yo chances ; )  Cheers !
Iseneschal - September 22, 2023

ELUT..... N.H.O.D

Cheers !
Iseneschal - September 20, 2023

ELUT....LoL...I like Jagdeesh says: "Back in Bowl"

I had to have a position in this cashed up cow...albeit ....small  Cheers !
Iseneschal - September 20, 2023
View more Bullboard ››

Lomiko Metals Inc.

Lomiko Metals Inc.

Lomiko Metals Inc. is a Canada-based company developing its flagship graphite property, La Loutre graphite in southern Quebec ...
View More »

Podcasts